ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2073

Ultrasound Findings of Activity in Patients with Inflammatory Myopathies and Clinical and Laboratory Comparison

Carina Soto-Fajardo1, Alejandra Espinosa-Orantes2, Alejandra Enríquez-Luna3, Fabian Carranza Enriquez4, Tabata Cano-Gamez3, Ana Mora-Rosas5, Rosa Elena Cervantes-Ramirez5, Karen Contreras-Castillo5, Jiram Torres Ruiz6, Diana Gómez-Martin7 and Carlos Pineda8, 1Instituto Nacional de Rehabilitacion "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico, 2Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Ciudad de México, Mexico, 3Instituto Nacional de Rehabilitacion, Mexico, Distrito Federal, Mexico, 4Instituto Nacional de Rehabilitación \"Luis Guillermo Ibarra Ibarra\", Ciudad de México, Mexico, 5Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico, Distrito Federal, Mexico, 6INCMNSZ, Mexico, Federal District, Mexico, 7INCMNSZ, Mexico, Distrito Federal, Mexico, 8Instituto Nacional de Rehabilitacion, Mexico City, Distrito Federal, Mexico

Meeting: ACR Convergence 2024

Keywords: Measurement Instrument, Musculoskeletal Examination, Myopathies, Myositis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Muscle ultrasound (MUS) is a non-invasive tool that may explore the extent of muscle abnormalities and contribute to early diagnosis and follow-up of patients with Idiopathic inflammatory myopathies (IIM). This study aims to compare the ultrasonographic findings with the clinical features of disease activity of patients with IIM.

Methods: Cross-sectional study that included patients older than 18 with IIM according to the 2017 ACR/EULAR classification criteria. We evaluated the patients according to the core set measures of the International Myositis Assessment and Clinical Studies (IMACS) group. According to the clinical and laboratory evaluation (muscle weakness, decrease in MMT8 score, and elevation of creatine kinase), the patients were divided into active and inactive patients. The MUS was performed using a GE LOGIQTMe machine with a 4-12 MHz linear probe. Ten muscles were evaluated bilaterally: sternocleidomastoid, deltoid, biceps brachii, extensor carpi radialis longus, quadriceps femoris, tibialis anterior, gastrocnemius, gluteus minimus, medius, and maximus. The Siena Myositis Ultrasound Grading Scale (SMUGS) was used to evaluate muscle edema, echo-intensity changes, muscle atrophy, and power Doppler signal (PD). The sonographer was blinded to clinical and laboratory data. Descriptive analyses were performed, and we determined the sensitivity and specificity of MUS to diagnose muscle disease activity; a p-value of ≤0.05 was considered statistically significant.

Results: Eighty-seven patients were recruited. Most patients were women (71.3%). The median (interquartile range, IQR) age was 49 (33-57). The most frequent diagnosis was dermatomyositis, presented in 67 patients (77%), followed by anti-synthetase syndrome in 12 patients (13.8%), polymyositis in 2 (2.3%), and overlap myositis in 6 (6.9%). Forty-five patients (51.7%) had active myositis. Muscle edema in sternocleidomastoid, gastrocnemius, biceps brachii, and extensor carpi radialis longus were associated with muscle activity (p< 0.05). The presence of edema  defined by MUS as hypoechoic areas with septa diffusely less evident in 3 individual muscle groups to identify disease activity has a sensitivity of 87% and specificity of 80%, with an area under the curve of 0.83 (0.74-0.92).

Conclusion: The MUS, as demonstrated, allows the identification of patients with clinically active disease. This makes it a potential screening tool for suspected activity in patients with IIM, aiding in their timely and effective management.

Supporting image 1

Figure 1. Ultrasound of the deltoid muscle. A. grade 2 edema and grade 2 PD signal, grade 2 atrophy. B edema, grade 0 PD signal and atrophy.


Disclosures: C. Soto-Fajardo: None; A. Espinosa-Orantes: None; A. Enríquez-Luna: None; F. Carranza Enriquez: None; T. Cano-Gamez: None; A. Mora-Rosas: None; R. Cervantes-Ramirez: None; K. Contreras-Castillo: None; J. Torres Ruiz: None; D. Gómez-Martin: None; C. Pineda: None.

To cite this abstract in AMA style:

Soto-Fajardo C, Espinosa-Orantes A, Enríquez-Luna A, Carranza Enriquez F, Cano-Gamez T, Mora-Rosas A, Cervantes-Ramirez R, Contreras-Castillo K, Torres Ruiz J, Gómez-Martin D, Pineda C. Ultrasound Findings of Activity in Patients with Inflammatory Myopathies and Clinical and Laboratory Comparison [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/ultrasound-findings-of-activity-in-patients-with-inflammatory-myopathies-and-clinical-and-laboratory-comparison/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-findings-of-activity-in-patients-with-inflammatory-myopathies-and-clinical-and-laboratory-comparison/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology